Skip to content
Clinical Trials – home
Odense University Hospital
Sponsor

Odense University Hospital

Denmark J B Winsloews Vej 4, 5000 Odense, Denmark

About the sponsor

Clinical research at Odense University Hospital includes acute coronary syndromes, atrial fibrillation, heart failure, aortic stenosis, and cardiac arrest, with additional work in post-operative atrial fibrillation and hypotension.

  • Acute coronary syndromes
  • Atrial fibrillation
  • Heart failure
  • Aortic stenosis
  • Cardiac arrest

Research activity also extends to antiplatelet therapy, anticoagulant therapy, and perioperative cardiac risk after surgical aortic valve replacement.

About Specializations

Odense University Hospital runs clinical trials in conditions such as Osteoporosis, Renal transplant, Osteoporosis postmenopausal, Plasma cell myeloma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

53 clinical trials

Discontinuing Acetylsalicylic Acid vs Continued Use in Patients ≥ 65 Years with Stable Chronic Coronary Syndrome

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Odense University Hospital

Phase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pomalidomide
  • Sponsor:Odense University Hospital

Comparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin Sodium
  • Sponsor:Odense University Hospital

Ovarian cancer

Recruiting

A Study of Carboplatin Given Directly into the Abdomen After Surgery in Elderly and Frail Patients with Ovarian Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Carboplatin
  • Sponsor:Odense University Hospital

Study of Everolimus and Resistance Training to Improve Bone Formation in Healthy Postmenopausal Women

Registered drug
Countries:DenmarkDenmark
  • Participants:65+ years · Healthy volunteers
  • Substances:Everolimus
  • Sponsor:Odense University Hospital

Study of intraperitoneal chemotherapy (PIPAC) with cisplatin and doxorubicin combined with minimally invasive surgery in patients with high-risk gastric cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Odense University Hospital

Study on the Safety and Effectiveness of Dapagliflozin for Kidney Function in Non-Diabetic Kidney Transplant Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Odense University Hospital

Study on Everolimus and Exercise to Prevent Bone Loss in Healthy Postmenopausal Women

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:Everolimus
  • Sponsor:Odense University Hospital

Colitis ulcerative+1

Recruiting

Study on Vedolizumab and Ustekinumab for Patients with Crohn's Disease and Ulcerative Colitis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ustekinumab
  • Sponsor:Odense University Hospital

Aortic stenosis

Recruiting

Study on the Effects of Losartan Potassium in Patients with Mild to Moderate Aortic Stenosis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Losartan Potassium
  • Sponsor:Odense University Hospital

Cancer fatigue

Recruiting

Study on Methylphenidate for Reducing Fatigue in Childhood Brain Tumor Survivors

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Methylphenidate
  • Sponsor:Odense University Hospital

Osteoporosis

Recruiting

Study on the Effects of Stopping Alendronic Acid in Patients with Osteoporosis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alendronic Acid
  • Sponsor:Odense University Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.